Skip to main content Skip to main navigation
Rijksoverheid logo | to homepage of RIVM National Institute for Public Health and the Environment Ministry of Health, Welfare and Sport
  • Nederlands
  • English
RIVM Committed to health and sustainability
  • Home
  • Topics
  • About RIVM
  • Publications
  • International
  • Contact
  • Agenda
  • MijnRIVM
  • Nederlands
  • English
  • Home
  • Search

Search


Search

Fill in your search phrase.

Type

Selecting an option will change the focus to the start of the list.
  • Page (7)

Publication date

Selecting an option will change the focus to the start of the list.
  • March 2026 (1)
  • November 2025 (1)
  • February 2020 (1)
  • February 2014 (4)

Topics

Selecting an option will change the focus to the start of the list.
  • (-) Breast Cancer Screening Programme (4)
  • (-) Meningococcal disease (3)
  • International (185)
  • COVID-19 (96)
  • International projects (64)
  • Nanotechnology and advanced materials (53)
  • Food safety (22)
  • Circular economy (20)
  • RIVM (20)
  • Soil and water (20)
  • Flu and flu vaccine (19)
  • Tobacco (17)
  • WHO Collaborating Centre for Risk Assessment of Pathogens in Food and Water (17)
  • Alternatives to animal testing (15)
  • Antimicrobial resistance (15)
  • Behavioural science (15)
  • Consumer exposure to chemical substances (15)
  • Heat (15)
  • National Immunisation Programme (14)
  • Food and Nutrition (13)
  • Rubber granulate (13)
  • Sexually transmitted infections (STIs) (13)
  • Health research for COVID-19 (12)
  • Immunisation and vaccination (11)
  • Incidents and disasters (11)
  • Infectious Disease Control (11)
  • Mpox (11)
  • Occupational Safety (11)
  • Plastics (11)
  • Cervical cancer screening programme (10)
  • ConsExpo (10)
  • One Health (10)
  • PFAS (10)
  • Tick bites (10)
  • Dutch National Food Consumption Survey (9)
  • Medical devices (9)
  • Public Health Foresight (9)
  • WHO Collaborating Centre for Laboratory Preparedness and Response for High Threat Pathogens and Biorisk (9)
  • Zoonotic diseases (9)
  • Mental Health (8)
  • Tuberculosis (8)
  • WHO Collaborating Centre for Tobacco Product Regulation and Control (8)
  • WHO Collaborating Centre on Chemical Food Safety (8)
  • Pneumococci (7)
  • Respiratory infections (7)
  • Sustainability (7)
  • West Nile fever (7)
  • Mosquitos (6)
  • National Security (6)
  • Population screening programs in the Caribbean Netherlands (6)
  • Climate change and Health (5)
  • Food contact materials (5)
  • Healthy living environment (5)
  • Measles (5)
  • Nitrogen (5)
  • Respiratory syncytial virus (RSV) (5)
  • WHO Collaborating Centre for Infectious Disease Preparedness and IHR monitoring and evaluation (5)
  • Biobased economy (4)
  • Bisphenol A (BPA) (4)
  • Dengue (4)
  • Endocrine disrupting chemicals (4)
  • Gonorrhoea (4)
  • HPV (4)
  • PIENTER Corona Study (4)
  • Population screening programmes (4)
  • Public Health Monitors (4)
  • Sustainable Development Goals (4)
  • Whooping cough (4)
  • Bird flu (avian influenza) (3)
  • Chromium (VI) and CARC (3)
  • Climate change (3)
  • DNA and public health (3)
  • Electromagnetic Fields (3)
  • Group A Strep infections (3)
  • Life Cycle Assessment (LCA) (3)
  • Lyme disease (3)
  • Malaria (3)
  • Physical Activity (3)
  • Tick-borne encephalitis (3)
  • UV index (3)
  • Wastewater research (3)
  • WHO Collaborating Centre for Immunotoxicology and Allergic Hypersensitivity; discontinued (3)
  • WHO Collaborating Centre for Nutrition (3)
  • Chikungunya (2)
  • Coronaviruses (2)
  • Ebola (2)
  • EU Reference Laboratory for Public Health on Vector-borne Viral Pathogens (EURL-PH-VBV) (2)
  • Legionella (Legionellosis) (2)
  • Lifestyle Monitor: public health monitoring of lifestyle and health in the Netherlands (2)
  • Livestock farming and health (2)
  • PFAS (2)
  • Probit functions (2)
  • Radiation and radioactivity (2)
  • Rubber tiles (2)
  • Salmonella (2)
  • WHO Collaborating Centre for Antimicrobial Resistance Epidemiology and Surveillance (2)
  • Zika Virus (2)
  • Arboviruses (1)
  • Bestrijdingsmiddelen (1)
  • Chickenpox (1)
  • Contact (1)
  • Corona (1)
  • Digitale zorg (1)
  • Doetinchem Cohort Study (1)
  • Dutch Food Composition Database (NEVO) (1)
  • Environmental and industrial safety (1)
  • Exploratory study into environmental pollution and health on Bonaire (1)
  • Fipronil in eggs (1)
  • Global Health Security (1)
  • Health promotion (1)
  • Healthy City (1)
  • Heel prick (1)
  • Hepatitis A (1)
  • Hepatitis B (1)
  • HPV - Humaan Papillomavirus (1)
  • Lifestyle interventions (1)
  • Marburg virus disease (1)
  • Meldpunt en Expertisecentrum Bijwerkingen Implantaten (1)
  • MERS (1)
  • NoroNet (1)
  • One Health (1)
  • Perinatal screening (1)
  • Pharmaceuticals in the environment (1)
  • Polio (1)
  • Rotavirus (1)
  • Scabies (1)
  • Shigellosis (1)
  • Shingles (1)
  • Synthetic biology (1)
  • WHO Collaborating Centre for Smallpox Vaccine (1)
  • WHO Collaborating Centre for the Family of International Classifications (FIC) (1)
  • WHO Collaborating Centre on Life Course and Health (1)

7 search results

You searched for these word(s): risk assessment
  • Procedure

    https://www.rivm.nl/en/breast-cancer-screening-programme/procedure

    … screening, the woman receives a letter informing her of the assessment’s result. Women neither attending screening nor … a reminder a few weeks later. Referral The various possible assessment results and the implications of each are …

    Publication date: 02-27-2014
  • Breast cancer in the Netherlands

    https://www.rivm.nl/en/breast-cancer-screening-programme/breast-cancer-in-netherlands

    … prevalence of 128,000. Factors associated with an elevated risk of breast cancer are: a family history of prevalent … use of oral contraception; dense breast tissue. Other risk factors are alcohol consumption, physical inactivity …

    Publication date: 02-27-2014
  • Facts and figures

    https://www.rivm.nl/en/breast-cancer-screening-programme/background/facts-and-figures

    … screened 24,5 Positive predictive value (pvv) recall 28% Risk reduction in mortality 50% (in case of regular … are considered: Advantages of the program Health gain Risk reduction Less invasive treatment due to early …

    Publication date: 02-27-2014
  • Current information on meningococcal disease

    https://www.rivm.nl/en/meningococcal-disease/current-information

    … nightclub Club Chemistry between 5 and 15 March 2026 The risk to the general population in the United Kingdom is … all pupils and students in the United Kingdom, only to the risk groups mentioned above. Travellers to the United …

    Publication date: 03-18-2026
  • Background

    https://www.rivm.nl/en/breast-cancer-screening-programme/background

    … there should be consensus as to who is ill or most at risk Screeningtest: the screeningtest should be easy to use …

    Publication date: 02-27-2014
  • Vaccination against meningococcal A, C , W and Y

    https://www.rivm.nl/en/meningococcal-disease/vaccination-meningococcal-acwy

    … the bacterial infection that they die. Fortunately, the risk to get ill due to meningococcal bacteria is very low. …

    Publication date: 11-25-2025
  • EpIg Men

    https://www.rivm.nl/en/international-projects/eplg-men

    … in different age groups with increased carriage and/or risk of meningococcal invasive disease were analysed. The …

    Publication date: 02-24-2020

Service

  • Contact
  • Information for the press
  • Working for RIVM
  • Complaints
  • Submitting WOO requests to RIVM
  • Doing business with RIVM
  • Huisregels sociale media

About this site

  • Cookies
  • Privacy
  • Accessibility
  • Disclaimer and copyright
  • Coordinated Vulnerability Disclosure
  • Website archive

Languages

  • English
  • Nederlands

Follow us

  • RIVM Newsletters
  • RSS feed
  • X Twitter
  • Facebook
  • LinkedIn
  • Youtube
  • Instagram
  • Mastodon